首页> 外文期刊>Virus Research: An International Journal of Molecular and Cellular Virology >Post translational modifications of recombinant human papillomavirus type 6b major capsid protein.
【24h】

Post translational modifications of recombinant human papillomavirus type 6b major capsid protein.

机译:重组人乳头瘤病毒6b型主要衣壳蛋白的翻译后修饰。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

We have determined the post-translational modifications of the major capsid protein, L1 of human papillomavirus (HPV) type 6b. Since this virus cannot be cultured in the laboratory to obtain sufficient material for a study, a recombinant L1 protein produced in a vaccinia virus expression system was used in this investigation. Our results show that this protein is phosphorylated at serine residues and is also glycosylated. No myristoylation or palmitoylation was detected. The fraction of L1 protein incorporated into virus-like particles was not glycosylated. Since recombinant L1 protein is a potential human vaccine candidate, knowledge of the post-translation modifications of this protein may prove useful for the design of anti-HPV vaccines.
机译:我们已经确定了主要衣壳蛋白L1型人乳头瘤病毒(HPV)6b的翻译后修饰。由于无法在实验室中培养此病毒以获得足够的研究材料,因此在该研究中使用了在牛痘病毒表达系统中产生的重组L1蛋白。我们的结果表明,该蛋白在丝氨酸残基处被磷酸化,并且也被糖基化。未检测到肉豆蔻酰化或棕榈酰化。掺入病毒样颗粒的L1蛋白部分未糖基化。由于重组L1蛋白是潜在的人类疫苗候选物,因此对该蛋白的翻译后修饰的了解可能证明对设计抗HPV疫苗有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号